Clinical Trial Update: ECLIPSE Feasibility Trial (Ensure's Vascular Closure Device Speeds Hemostasis Trial) EU [Phase 1]

View source ↗

Summary

Phase 1 feasibility study of an ECLIPSE vascular closure device completed in Europe, assessing speed of hemostasis after transcatheter coronary procedures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• ECLIPSE Vascular Closure Device

Snippet

Sponsor: Cordis US Corp. | Conditions: Angioplasty, Transluminal, Percutaneous Coronary, Coronary Arteriosclerosis | Phase 1 | Status: COMPLETED